These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37078828)

  • 1. Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer.
    Zhu H; Yu H; Zhou H; Zhu W; Wang X
    Adv Sci (Weinh); 2023 Jun; 10(17):e2205818. PubMed ID: 37078828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism.
    Shu Y; Hao Y; Feng J; Liu H; Li ST; Feng J; Jiang Z; Ye L; Zhou Y; Sun Y; Zhou Z; Wei H; Gao P; Zhang H; Sun L
    EMBO J; 2022 Dec; 41(23):e111550. PubMed ID: 36314841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling.
    Cai Z; Li W; Hager S; Wilson JL; Afjehi-Sadat L; Heiss EH; Weichhart T; Heffeter P; Weckwerth W
    Cell Mol Immunol; 2024 May; 21(5):448-465. PubMed ID: 38409249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.
    Dong JK; Lei HM; Liang Q; Tang YB; Zhou Y; Wang Y; Zhang S; Li WB; Tong Y; Zhuang G; Zhang L; Chen HZ; Zhu L; Shen Y
    Theranostics; 2018; 8(7):1808-1823. PubMed ID: 29556358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate.
    Wu YQ; Zhang CS; Xiong J; Cai DQ; Wang CZ; Wang Y; Liu YH; Wang Y; Li Y; Wu J; Wu J; Lan B; Wang X; Chen S; Cao X; Wei X; Hu HH; Guo H; Yu Y; Ghafoor A; Xie C; Wu Y; Xu Z; Zhang C; Zhu M; Huang X; Sun X; Lin SY; Piao HL; Zhou J; Lin SC
    Cell Res; 2023 Nov; 33(11):835-850. PubMed ID: 37726403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
    Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z
    J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
    Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
    Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
    Yoshino H; Enokida H; Osako Y; Nohata N; Yonemori M; Sugita S; Kuroshima K; Tsuruda M; Tatarano S; Nakagawa M
    Mol Oncol; 2020 Sep; 14(9):2190-2202. PubMed ID: 32386122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
    Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
    Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells.
    Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S
    Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHGDH: a novel therapeutic target in cancer.
    Lee CM; Hwang Y; Kim M; Park YC; Kim H; Fang S
    Exp Mol Med; 2024 Jul; 56(7):1513-1522. PubMed ID: 38945960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
    Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
    Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
    Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
    Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
    Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
    Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yap/Taz activity is associated with increased expression of phosphoglycerate dehydrogenase that supports myoblast proliferation.
    Meinhold M; Verbrugge S; Shi A; Schönfelder M; Becker L; Jaspers RT; Zammit PS; Wackerhage H
    Cell Tissue Res; 2024 Mar; 395(3):271-283. PubMed ID: 38183459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
    Jeon MJ; You MH; Han JM; Sim S; Yoo HJ; Lee WK; Kim TY; Song DE; Shong YK; Kim WG; Kim WB
    Thyroid; 2020 Nov; 30(11):1625-1638. PubMed ID: 32438862
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetylation Stabilizes Phosphoglycerate Dehydrogenase by Disrupting the Interaction of E3 Ligase RNF5 to Promote Breast Tumorigenesis.
    Wang C; Wan X; Yu T; Huang Z; Shen C; Qi Q; Xiang S; Chen X; Arbely E; Ling ZQ; Liu CY; Yu W
    Cell Rep; 2020 Aug; 32(6):108021. PubMed ID: 32783943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of ESRP1 in the Regulation of PHGDH in Estrogen Receptor-Positive Breast Cancer.
    Gökmen-Polar Y; Gu Y; Polar A; Gu X; Badve SS
    Lab Invest; 2023 Mar; 103(3):100002. PubMed ID: 36925195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy.
    Zhang D; Li AM; Hu G; Huang M; Yang F; Zhang L; Wellen KE; Xu X; Conn CS; Zou W; Kahn M; Rhoades SD; Weljie AM; Fuchs SY; Amankulor N; Yoshor D; Ye J; Koumenis C; Gong Y; Fan Y
    Cell Metab; 2023 Mar; 35(3):517-534.e8. PubMed ID: 36804058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.